Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 9/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | SMO | Q99835 | 2/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22102810 | 0.86 | MCL1 (0.36) | MCL1ADORA3ADORA2BADORA1MEN1 | |
| SCHEMBL20936376 | 0.85 | MCL1 (0.41) | MCL1ADORA3ADORA2BADORA1MEN1 | |
| SCHEMBL19368575 | 0.81 | MCL1 (0.41) | MCL1ADORA3ADORA2BADORA1MEN1 | |
| SCHEMBL24627008 | 0.81 | KDM4E (0.34) | ADORA3ADORA2BADORA1EGFRCYP19A1 | |
| SCHEMBL24589096 | 0.77 | MCL1 (0.37) | MCL1ADORA3ADORA2BADORA1MEN1 | |
| SCHEMBL19216510 | 0.75 | MCL1 (0.34) | MCL1ADORA3ADORA2BADORA1 | |
| SCHEMBL21975598 | 0.75 | ADORA1 (0.41) | MCL1ADORA3ADORA2BADORA1MEN1 | |
| SCHEMBL17932831 | 0.75 | CYP19A1 (0.53) | ADORA3ADORA2BADORA1SMOPIM1 | |
| SCHEMBL23570767 | 0.74 | MEN1 (0.43) | ASIC3MEN1KMT2A | |
| SCHEMBL23193330 | 0.72 | MCL1 (0.38) | MCL1ADORA3ADORA2BADORA1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230301179-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20230269997-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-24 | — | — | US | disclosed |
| US-20230146532-A1 | LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230269997-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR THE SAME | LAGE3, CRY1, CRY2 | MCL1 3528/4885ADORA3 3905/4885ADORA2B 4388/4885 |
| US-20230146532-A1 | LIGHT EMITTING DEVICE | LAGE3, CRY2, EML4 | MCL1 3841/4885ADORA3 2679/4885ADORA2B 2595/4885 |
| US-20230301179-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | CRY1, AOX1, CYP1A1 | MCL1 2219/4885ADORA3 3902/4885ADORA2B 3961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.